Find clinical trials for Multiple Myeloma in Los Angeles, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Los Angeles, CA, USA:
This is a pilot study evaluating the safety and efficacy of selinexor among multiple myeloma (MM) patients that are refractory to l...
Phase 1
West Hollywood, California, United States of America
This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...
Phase 1
West Hollywood, California, United States and 12 other locations
A phase 2 study of venetoclax in combination with isatuximab and dexamethasone for relapsed/refractory multiple myeloma patients wi...
Phase 2
West Hollywood, California, United States and 1 other location
a phase 1b, open-label, dose-escalation study of STI-1492 administered by a single intravenous infusion in subjects with relapsed or refractory multiple...
Phase 1
Orange, California, United States and 2 other locations
This is a Phase I dose-finding study of FT576 as monotherapy and in combination with the monoclonal antibody daratumumab in multiple myeloma...
Phase 1
Duarte, California, United States and 13 other locations
The purpose of this study is to evaluate the safety and preliminary efficacy of CC-95266 in participants with relapsed and/or refractory multiple...
Phase 1
Duarte, California, United States and 9 other locations
The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...
Phase 2
Duarte, California, United States and 9 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Los Angeles, California, United States and 59 other locations
phases, for the treatment of patients with relapsed/refractory multiple myeloma (RRMM) and newly diagnosed multiple myeloma...
Phase 1, Phase 2
Los Angeles, California, United States and 24 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Duarte, California, United States and 139 other locations
Clinical trials
Research sites
Resources
Legal